Can durvalumab or savolitinib alone or in combination with tremelimumab improve survival in patients with metastatic kidney cancer?
At the American Society of Clinical Oncology (ASCO) Annual Meeting [...]
Differences in survival with tremelimumab due to different types of kidney cancer
Most people have a type of kidney cancer called clear [...]
